本システムでは、JavaScriptを利用しています。JavaScriptを有効に設定してからご利用ください。
Skip to main content
Contact Us
FONT SIZE
normal
large
LANGUAGE
JP
EN
HOME
About ASKA Pharmaceutical Holdings
Top Message
Corporate Philosophy
Company Overview
Charter of Corporate Behavior
Board Members and Corporate Officers
Group Companies
Business Activities
Corporate History
Organization Chart
Corporate Message
ASKA Pharmaceutical Holdings in Numbers
Policies
Access Map
For Our Shareholders and Investors
IR News
IR Library
IR Calendar
Management Strategies and Policies
Governance
Pipeline and Intellectual Property
Financial Highlights
ASKA Pharmaceutical Holdings at a glance
Stock Information
Disclaimer
IR E-mail Newsletter Service
IR Site Map
Recommended Route to Access Our IR Website
Sustainability
Our Sustainability
Environmental
Social
Governance
ESG Chart and ESG Data Book
External Evaluation
Initiatives and Member Organizations
Third-party Opinion
Sustainability News
Various Contrasting Tables
Policies
Integrated Report
Press Releases
Contact Us
Privacy Policy
Basic Policy on the Proper Handling of Specific Personal Information, etc.
Terms of Use
Site Policy
Cookie Policy
SNS コミュニティ・ガイドライン
公式Webサイト・SNS
Sitemap
About ASKA Pharmaceutical Holdings
Company Overview
Group Companies
Top Message
Corporate Philosophy
Company Overview
Charter of Corporate Behavior
Board Members and Corporate Officers
Group Companies
Business Activities
Corporate History
Organization Chart
Corporate Message
ASKA Pharmaceutical Holdings in Numbers
Policies
Access Map
For Our Shareholders and Investors
Top Message
Medium-Term Management Plan
ASKA Pharmaceutical Holdings at a glance
IR News
IR Library
IR Calendar
Management Strategies and Policies
Governance
Pipeline and Intellectual Property
Financial Highlights
ASKA Pharmaceutical Holdings at a glance
Stock Information
Disclaimer
IR E-mail Newsletter Service
IR Site Map
Recommended Route to Access Our IR Website
Sustainability
Integrated Report
Our Basic Policy for Sustainability
Various Contrasting Tables
Our Sustainability
Top Commitment
Our Basic Policy for Sustainability
Materiality
Value Creation Process
Initiatives for Sustainability and SDGs
Importance of Female Healthcare and Social Issues
Disclosures based on TCFD recommendations
Environmental
Governance
External Evaluation
Third-party Opinion
Various Contrasting Tables
Integrated Report
Social
ESG Chart and ESG Data Book
Initiatives and Member Organizations
Sustainability News
Policies
HOME
>
HOME
>
Sustainability
>
Sustainability News
Sustainability News
PRINT
FY2024
FY2023
FY2022
FY2021
FY2024
2024年12月17日
Received the Excellence Award in the Business Category of the “2024 Tokyo Women's Advancement Promotion Award” (Japanese version only)
November 5, 2024
Integrated Report 2024 (ASKA HD REPORT 2024) has been disclosed
September 24, 2024
ASKA Pharmaceutical changes the packaging of its pharmaceutical products in consideration of the environment. (Japanese version only)
August 9, 2024
ESG Data Book 2024 is now available
June 17, 2024
ASKA Pharmaceutical Obtains "FIT Non-Fossil Certificate/Renewable Energy Certificate" for its Head Office Building (Japanese version only)
June 14, 2024
ASKA Pharmaceutical Begins Receiving Solar-Powered Electricity from On-Site PPA (Japanese version only)
May 20, 2024
May 25th is World Thyroid Day (Japanese version only)
April 23, 2024
ASKA Pharmaceutical Exhibits at the 4th HEALTH MANAGEMENT EXPO SPRING (Japanese version only)
April 1, 2024
ASKA Pharmaceutical Initiates “Work Support Grant” Program and Cancer Insurance Program for All Regular Employees
FY2023
February 22, 2024
ESG Data Book has been updated
October 31, 2023
Integrated Report 2023 (ASKA HD REPORT 2023) has been uploaded
July 10, 2023
ESG Data Book has been updated
April 21, 2023
ASKA Pharmaceutical Holdings Installs CO₂-Free Electricity and Solar Power Generation Facilities
April 3, 2023
Message from Board Member in Charge of Sustainability has been posted
FY2022
March 30, 2023
The web page "Decarbonization Initiatives" has been disclosed
March 8, 2023
ASKA Pharmaceutical Holdings Recognized as a White 500 enterprise for the Fifth Consecutive Year
February 13, 2023
ESG Data Book has been updated
October 27, 2022
Integrated Report 2022 (ASKA HD REPORT 2022) has been uploaded
October 14, 2022
ESG Data Book has been updated
June 6, 2022
The web page "Disclosures based on TCFD recommendations" has been disclosed
FY2021
February 14 2022
Signing the United Nations Global CompactFinancial Results Presentation Material for FY2021
December 27, 2021
The web pages "Materiality" and "ESG Data Book" have been disclosed
April 1, 2021
The website of ASKA Pharmaceutical Holdings has been opened
Please download the free
Adobe Acrobat Reader DC
to view it.
About ASKA Pharmaceutical Holdings
Top Message
Corporate Philosophy
Company Overview
Charter of Corporate Behavior
Board Members and Corporate Officers
Group Companies
Business Activities
Corporate History
Organization Chart
Corporate Message
ASKA Pharmaceutical Holdings in Numbers
Policies
Access Map
For Our Shareholders and Investors
IR News
IR Library
IR Library
Financial Results
Annual Securities Report
Integrated Report
Shareholder Newsletters (Japanese version only)
Shareholders' Meeting
Fact Sheet
IR Calendar
Management Strategies and Policies
Management Strategies and Policies
Top Message
Medium-Term Management Plan
Business Risks
Disclosure Policy
Governance
Governance
Basic Principles / Corporate Governance Structure
Corporate Governance Basic Policy
Corporate Governance Report (Japanese version only)
Board Members
Compliance / Risk Management
Internal Control System
Dialogue with Shareholders
Roundtable Discussion with Outside Directors
Material Issues: G
ESG Chart and ESG Data Book
Pipeline and Intellectual Property
Financial Highlights
Financial Highlights
Performance Review
Performance Highlights
Financial Conditions
Financial Statements
Consolidated Balance Sheets
Consolidated Statements of Income
Consolidated Statements of Cash Flows
Earnings Forecast
Non-Financial Highlights (ESG Chart and ESG Data Book)
ASKA Pharmaceutical Holdings at a glance
ASKA Pharmaceutical Holdings at a glance
Point1 About ASKA - Understanding & History -
Point2 About ASKA - Our Strengths -
Point3 Highly Specialized Product Lineup
Point4 Continuously Evolving R&D
Point5 Stable Shareholder Returns
Business Model
Frequently Asked Questions
Stock Information
Stock Information
Stock summary information
Shareholder Information
Shareholders' Meeting
Stock Price Information
Dividends and Dividend Payout Ratio
Articles of Incorporation and Stock Handling Regulations
Analyst Coverage
Disclaimer
IR E-mail Newsletter Service
IR Site Map
Recommended Route to Access Our IR Website
Sustainability
Our Sustainability
Our Sustainability
Top Commitment
Our Basic Policy for Sustainability
Materiality
Value Creation Process
Initiatives for Sustainability and SDGs
Importance of Female Healthcare and Social Issues
Disclosures based on TCFD recommendations
Environmental
Environmental
Basic Environmental Philosophy / Environmental Policies
Material Issues: E
Disclosures Based on TCFD Recommendations
Decarbonization Initiatives
Initiatives for Water Resource
Initiatives for Recycle-Oriented Society and Biodiversity
ESG Chart and ESG Data Book
Environmental Management
Social
Social
Stakeholder Outcomes/Impact
Respect for Human Rights
Labour Practices
Diversity & Inclusion
Initiatives to Promote the Advancement of Women
Health Management Initiatives
Fair Operating Practices
Supply Chain
Customer Health and Safety
Social Contribution Activities（Community Involvement and Development）
Material Issues: S
ESG Chart and ESG Data Book
Governance
ESG Chart and ESG Data Book
External Evaluation
Initiatives and Member Organizations
Third-party Opinion
Sustainability News
Various Contrasting Tables
Policies
Integrated Report
Press Releases
Contact Us
Privacy Policy
Basic Policy on the Proper Handling of Specific Personal Information, etc.
Terms of Use
Site Policy
Cookie Policy
SNS コミュニティ・ガイドライン
公式Webサイト・SNS
Sitemap
TOP